Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. QURE
QURE logo

QURE

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

QURE News

FDA Leadership Shakeup May Impact Biotech Stocks

2d agostocktwits

ClearPoint Neuro and UniQure Stocks Surge Following WSJ Report on Trump's Potential Plan to Dismiss FDA Commissioner Marty Makary

2d agomoomoo

uniQure Q1 2026 Earnings Call Insights

5d agoseekingalpha

uniQure Q1 Earnings Beat Expectations Despite Revenue Miss

5d agoseekingalpha

uniQure Q1 Earnings Announcement Scheduled

6d agoseekingalpha

uniQure's Gene Therapy Receives Positive Regulatory Developments

Apr 30 2026seekingalpha

uniQure Advances Huntington's Disease Therapy with Regulatory Plans

Apr 30 2026stocktwits

uniQure Completes Successful Meeting with MHRA, Advancing AMT-130 Application

Apr 30 2026NASDAQ.COM

Capricor's Former Executive Considered for FDA Biologics Chief

Apr 14 2026stocktwits

uniQure Faces Class Action Lawsuit Notification

Apr 13 2026Globenewswire

uniQure Faces Class Action Lawsuit Reminder

Apr 13 2026PRnewswire

Reminder for uniQure N.V. Class Action Lawsuit

Apr 12 2026PRnewswire

uniQure Faces Severe FDA Rebuke Amid Class Action Lawsuit

Apr 10 2026Globenewswire

Faruqi & Faruqi Encourages UniQure Investors to Reach Out

Apr 10 2026PRnewswire

Notice of Class Action Lawsuit for uniQure Shareholders

Apr 09 2026Globenewswire

uniQure Faces Class Action Lawsuit from Investors

Apr 09 2026PRnewswire